Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1267_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
15 Мб
Скачать
☆
17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
can also vary between facilitated laparoscopic, laparoscopic assisted, and total lapa­roscopic approaches. Facilitated laparoscopy includes the combination of laparo­scopic and open approach: only mobilisation of the bowel is done laparoscopically. Subsequently, the vascular ligation, bowel transection, and anastomosis creation is done in an open fashion. In the laparoscopic assisted approach mobilisation and vascular division is done laparoscopically, and anastomosis creation is done outside the body. Finally, in the total laparoscopic approach all phases of the operation are done laparoscopically.
239

17.4.1 Open

Multiple factors are linked to using the open approach. One hard indication of open surgery is multiple prior open operations with extensive adhesions. However, the benets of laparoscopic surgery for IBD with regards to short- and long-term mor­bidity, including safety, efcacy, reduced postoperative complication, earlier recov­ery, and superior body image and cosmetics, are extensively reported and are now established [60–63]. Therefore, laparoscopic ileocolic resection is considered the preferred approach for strictures, as long as appropriate expertise is available. Ultimately, a good open operation is better than a bad laparoscopic one.

17.4.2 Handassisted

Indication for handassisted surgery are stulas of the terminal ileum to bladder, vagina and sigmoid. Using a handport located in a Pfannenstiel position, the stulas can safely be disconnected, followed by a handport mobilisation of the right colon. Furthermore, extraction of a more sizable specimens and inammatory masses is possible with handassistance, without converting to an open approach. In this way, cosmetics and incisional hernia rates can be compromised [64].

17.4.3 Multi-Port

Straight laparoscopic surgery via multi-port for Crohn’s disease was rst reported in 1992 [65]. For multi-port ileocolic resections, a camera port is introduced at the site of the umbilicus. Additionally, 2 or 3 ports are placed. Mobilisation of the right colon and the terminal ileum is performed from lateral to medial or medial to lat­eral. The ileocolic anastomosis can be done extra- or intracorporeally. The speci­men can be extracted through the umbilical incision by extending the umbilical port access or via a Pfannenstiel suprapubic incision, in case of a larger inamma­tory mass.
240
K. A. T. G. M. Wasmann et al.

17.4.4 Single-Port

The single-port technique was rst described in 2008 to further reduce the invasive­ness of the procedure by avoiding additional port sites [66, 67]. Single port ileocolic resections are performed using a port positioned at the umbilicus, suprapubically, or at the planned stoma site. This site also functions as the extraction site. Regular straight laparoscopic instruments can be used. Mobilisation of the ascending colon can be performed either from lateral to medial or the other way around, according to the surgeon’s preference. Again, the ileocolic anastomosis can be done extra- or intracorporeally. Some surgeons put the port suprapubically avoiding an incision in the umbilicus. The prerequisite of single port surgery is that the size of the specimen is relatively small in order to keep the skin incision within the limits of the umbilical folds. Technically, this can be done by a close bowel transection of the mesentery reducing the size of the specimen.

17.4.5 Single Port versus Multi-Port

Single port technique decreases the abdominal trauma by reducing the number of incision sites. Patients undergoing a single port report less postoperative pain with a reduction of the need for analgesics (including opiates) compared to multi-port patients [68]. Regarding postoperative complication, conversion rates to open sur­gery, and need of stoma creation, no differences between single port and multi-port are recorded. The main advantage of single port ileocolic resection over multi-port is the superior cosmesis limiting the number of scars to one at the umbilicus (Fig.17.1). Therefore, it represents the ideal surgical approach in predominantly
Fig. 17.1 Single port at umbilicus
17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
young CD patients with strong consideration to preserve the body image. Obviously, fewer incisional hernias will occur since single port surgery does not require addi­tional trocar sites. When the single port is placed in the future stoma site, an increase in parastomal hernias has been described, due to enlargement of the stoma site to facilitate the single port and the specimen extraction [69]. It must be stressed, that if single port is difcult, there is no argument against the later insertion of one or two additional trocars or a conversion to multi-port.
241

17.4.6 Decision Making

The approach and type of surgery depends on disease characteristics (e.g. size of the inammatory mass), multiple locations, patient characteristics (e.g. prior surgeries), and surgical characteristics (e.g. surgeon’s preference and expertise). Preoperative imaging of the inammatory process must guide the surgeon towards either open surgery or laparoscopic surgery with specimen extraction via umbilicus or Pfannenstiel incision. Sizable masses or stula towards pelvic organs are best approached via a laparoscopic procedure with a Pfannenstiel incision as the extrac­tion site, whereas the umbilical up and down incision is more suitable for limited masses. It is generally accepted that single-port surgery is more difcult to perform, due to a decrease in the range of motion for the surgeon. In case preoperative imag­ing was not informative to assist in deciding the best approach, it’s recommended to start with a diagnostic laparoscopy via the umbilicus and decide the most optimal approach during surgery [70] (Fig.17.2).

17.5 Anastomosis

For ileocolic resections four different types of anastomostic congurations are used: side-to-side isoperistaltic anastomosis, side-to-side anisoperistaltic anastomosis, end-to-side anastomosis, and end-to-end anastomosis (Figs.17.3, 17.4, 17.5, 17.6, and 17.7). Side-to-side (S-S) anastomosis can either be performed by the use of a stapler or handsewn, and end-to-side (E-S) and end-to-end (E-E) only by handsewn. Handsewn anastomosis can be performed as a single-layer or a two-layer anastomo­sis, depending on the preference of the surgeon. S-S anastomosis consist of isoperi­staltic and anisoperistaltic anastomosis. In isoperistaltic anastomosis the fecal stream remains in the original direction (functional end-to-end anastomosis), whereas anisoperistaltic anastomosis interfere with the fecal stream. Grossly, the isoperistaltic stapled S-S is done by close stapling of the resection margins, fol­lowed by resection of a corner of the resection line to pass the stapler and construct a S-S anastomosis (Fig.17.3). Anisoperistaltic stapled S-S is done by enterotomies of the resection margins, next the stapler is passed through both enterotomies to create a S-S anastomosis (Fig. 17.4). The observation that recurrence almost
242
Fig. 17.2 Patient before and after single port ileocolic surgery
K. A. T. G. M. Wasmann et al.
Fig. 17.3 Isoperistaltic S-S handsewn [71]
17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
Fig. 17.4 Anisoperistaltic S-S handsewn
243
Fig. 17.5 Anisoperistaltic S-S stapled
244
Fig. 17.6 S-E handsewn
Fig. 17.7 E-E handsewn
K. A. T. G. M. Wasmann et al.
invariably appears at the anastomotic site, has led to the assumption that the type of anastomosis could matter. In the literature, predominantly data comparing S-S ver­sus E-E exist. Two studies, including one RCT, showed superiority of stapled anas­tomosis for anastomotic leakage. For surgical recurrence only a trend of delayed
17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
surgical recurrence compared to handsewn anastomoses was observed [72, 73]. Usually, S-S is a wider anastomosis compared to an E-E anastomosis, less resis­tance suggests S-S would lead to less complication and postoperative recurrence. This hypotheses was supported for short term outcomes in four meta-analyses, as S-S anastomosis reduced overall postoperative complications and anastomotic leak­age rate, compared to handsewn E-E anastomosis [58, 73–75]. One of the meta­analyses specically compared stapled isoperistaltic S-S versus handsewn E-E and reported superiority of the S-S anastomosis for short term-outcomes [75]. This has not been conrmed in RCT’s, reporting similar surgical outcomes, e.g. anastomotic leakage rates, for stapled S-S anastomosis and handsewn E-E anastomosis [76, 77]. Concerning long-term effects, it is hypothesized that a higher resistance to the fecal stream is associated with a higher recurrence rate. Probably all four techniques have a different resistance to the fecal stream, either due to the width of the anastomosis or due to the anti- or isoperistaltic direction. Therefore, the existing evidence directs the surgeon towards using a wide anastomosis of which the aniso- and isoperistaltic anastomosis are the best in this respect [74, 75]. The disadvantages of anisoperital­tic anastomoses are difcult intubation by colonoscopy, and of isoperistaltic anasto­moses the creation of a blind loop on both sides of the anastomosis. Taken these studies together with the practical consideration, aniso- or isoperistaltic stapled S-S anastomosis are the preferred types of anastomosis.
245
17.6 Extent ofResection
Considering the relapsing entity of CD and the risk of short bowel syndrome caused by multiple resections, guidelines advise limited ileocolic resections of macroscopically involved bowel [78]. However, conicting ndings regarding the clinical relevance of inammation-free resection margins, and new insights into the possible role of the mesentery in recurrent disease and the extent of an ileocolic resection with respect to transection of bowel and mesentery is currently a topic of great interest.
17.6.1 Level ofBowel Transection
Guidelines are based on studies showing no prognostic value of inamed resection margins, and a RCT demonstrating no difference in extensive vs. limited ileocolic resection [79–81]. So far microscopic positive section margins are accepted as of no importance concerning recurrence. A recent cohort study identied disease activity at resection margins as an independent risk factor for CD recurrence [48]. But, it was difcult to draw clinical conclusions, as no uniform pathological denitions were used. Recently, a study was performed that microscopically analyzed the prox­imal (ileum) and distal (colon) resection margin separately. Inammation at the colonic resection margin, and not the ileal site, was associated to increase clinical
246
recurrence (K.A. Wasmann etal., submitted). This could explain previous discrep­ancy, as until now the discussion was focussed on the proximal resection margin. However, further research and validation studies are necessary to nally elucidate the clinical consequence of a positive ileum or colon resection margin.
K. A. T. G. M. Wasmann et al.
17.6.2 Extent ofResection ofMesentery
In benign IBD surgery the mesentery is spared and typically taken close to the bowel wall. Increasing evidence shows that the mesentery plays an active role in the pathophysiology of Crohn’s disease (it is hypothesized that it is an participant in the pathogenesis of bro-inammatory and pure brotic stenosis) [82–84]. In ulcerative colitis close rectal dissection with preservation of the mesorectum versus total mesorectal excision in ileal pouch-anal anastomosis reduces anastomotic leakage and improves quality of life [85]. In contrast, a study comparing postopera­tive outcomes in close rectal dissection versus total mesorectal excision proctec­tomy for therapy-refractory Crohn’s disease, leaving the mesorectum in situ, resulted in more perianal complications and decreased perianal healing (E. de Groof etal., submitted) [86]. Moreover, analyzing the mesorectum after close rec­tal dissection, ongoing pro-inammatory characteristics could be demonstrated. Although not established yet in clinical studies, it could be hypothesized that a more extended resection of the mesentery reduces postoperative recurrence. The question, if extended ‘oncological’ mesenteric resection, could reduce recurrence is currently addressed in two RCT’s (NCT02542904, and A.Lightner, 2017, open for inclusion).

17.7 Conclusion

In conclusion, clear indications for surgery of Crohn’s disease of the terminal ileum are patients with pure brotic strictures, patients with symptomatic stulis­ing disease and most of the patients with abscesses. Patients not responding to anti- inammatory therapy and immunomodulators, and having a combination of inammation and brotic stricture should be counselled for both medical (anti­TNF) and surgical therapy. This decision making must be done together with the patient (shared decision making). Furthermore, with the validation of a classica­tion of Crohn’s disease in the terminal ileum per phenotype (bro-inammatory disease, pure brotic disease, stulising disease, and stulising disease with abscess formation) standardized care per phenotype could be achieved. An RCT is recommended to determine the role of stricturoplasty over the valve compared to surgical resection for Crohn’s disease in the terminal ileum. For ileocolic resec­tion, eligible patients should undergo single port surgery with and stapled S-S anastomosis. As stated before, surgery is not a cure for stricturing Crohn’s disease.
17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
247
The 5-year clinical recurrence of surgery for bro-inammatory, pure brotic, s­tulizing, and stulizing with abscess disease, is up to 45%, and the 10-year surgical recurrence is approximately 20% [1, 48, 87]. Recurrence rate per phenotype have not been described yet. After ileocolic resection for all four phenotypes, postopera­tive recurrence at the anastomosis is the most common site. Conventional risk factors for postoperative recurrence are smoking, prior intestinal surgery, and absence of prophylactic treatment [78]. Studies analysing risk factors in resection margins and mesentery could determine the most effective extent of resection in Crohn’s disease.

References

1. Peyrin-Biroulet L, Loftus EV, Colombel J-F, Sandborn WJ.The natural history of adult Crohn’s
disease in population-based cohorts. Am J Gastroenterol. 2010;105(2):289–97. https://doi.
org/10.1038/ajg.2009.579. [cited 2017 May 23].
2. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, etal. Long-term evolution of
disease behavior of Crohn’s disease. Inamm Bowel Dis. 2002;8(4):244–50. http://www.ncbi.
nlm.nih.gov/pubmed/12131607. [cited 2017 Jun 29].
3. Cosnes J, Gowerrousseau C, Seksik P, Cortot A.Epidemiology and natural history of inam-
matory bowel diseases. Gastroenterology. 2011;140(6):1785–94.
4. Papi C, Festa V, Fagnani C, Stazi A, Antonelli G, Moretti A, et al. Evolution of clinical
behaviour in Crohn’s disease: predictive factors of penetrating complications. Dig Liver Dis. 2005;37(4):247–53. http://www.ncbi.nlm.nih.gov/pubmed/15788208. [cited 2017 Jun 29].
5. Beaugerie L, Seksik P, Nion–Larmurier I, Gendre J, Cosnes J.Predictors of Crohn’s disease.
Gastroenterology. 2006;130(3):650–6. http://www.ncbi.nlm.nih.gov/pubmed/16530505. [cited 2017 Jun 29].
6. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Ya FA, Belaiche J. Behaviour of
Crohn’s disease according to the Vienna classication: changing pattern over the course of the disease. Gut. 2001;49(6):777–82. http://www.ncbi.nlm.nih.gov/pubmed/11709511. [cited 2017 Jul 18].
7. Satsangi J, Silverberg MS, Vermeire S, Colombel J-F.The Montreal classication of inam-
matory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–53.
http://www.ncbi.nlm.nih.gov/pubmed/16698746. [cited 2017 May 3].
8. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV. Risk factors associ-
ated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139(4):1147–55. http://linkinghub.elsevier.com/retrieve/pii/
S0016508510010395. [cited 2017 Jun 6].
9. Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, et al. Clinical course in Crohn’s
disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5(12):1430–8. http://linkinghub.elsevier.com/retrieve/pii/S1542356507008889. [cited 2017 Jul 19].
10. Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, etal. Phenotype at diag-
nosis predicts recurrence rates in Crohn’s disease. Gut. 2006;55(8):1124–30. https://doi.
org/10.1136/gut.2005.084061. [cited 2017 Jul 19].
11. Panés J, Bouzas R, Chaparro M, García-Sánchez V, Gisbert JP, Martínez de Guereñu B,
et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34(2):125–45. http://www.ncbi.nlm.nih.gov/
pubmed/21615440. [cited 2017 Jun 6].
248
12. Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC, etal. Imaging techniques
for assessment of inammatory bowel disease: joint ECCO and ESGAR evidence- based consensus guidelines. J Crohns Colitis. 2013;7(7):556–85. http://www.ncbi.nlm.nih.gov/
pubmed/23583097. [cited 2017 Jun 6].
13. Fiorino G, Bonifacio C, Peyrin-Biroulet L, Minuti F, Repici A, Spinelli A, etal. Prospective
comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inamm Bowel Dis. 2011;17(5):1073–80. http://content.wkhealth.com/linkback/openurl?sid=WKPTL
P:landingpage&an=00054725-201105000-00002. [cited 2017 Jul 21].
14. Lautenbach E, Berlin JA, Lichtenstein GR.Risk factors for early postoperative recurrence
of Crohn’s disease. Gastroenterology. 1998;115(2):259–67. http://www.ncbi.nlm.nih.gov/
pubmed/9679030. [cited 2017 Jul 21].
15. Sachar DB, Subramani K, Mauer K, Rivera-MacMurray S, Turtel P, Bodian CA, etal. Patterns
of postoperative recurrence in stulizing and stenotic Crohn’s disease. A retrospective cohort study of 71 patients. J Clin Gastroenterol. 1996;22(2):114–6. http://www.ncbi.nlm.nih.gov/
pubmed/8742649. [cited 2017 Jul 21].
16. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in
Crohn’s disease. Ann Surg. 2000;231:38. https://insights.ovid.com/pubmed?pmid=10636100. [cited 2017 Jun 16].
17. Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R.Early versus late surgery for
ileo-caecal Crohn’s disease. Aliment Pharmacol Ther. 2007;26:1303–12.
18. Ramadas AV, Gunesh S, Thomas GAO, Williams GT, Hawthorne AB. Natural history of
Crohn’s disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59:1200.
19. Eshuis EJ, Peters CP, van Bodegraven AA, Bartelsman JF, Bemelman W, Fockens P, etal. Ten
years of iniximab for Crohn’s disease. Inamm Bowel Dis. 2013;19(8):1622–30. http://www.
ncbi.nlm.nih.gov/pubmed/23552767. [cited 2017 Jun 14].
20. Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J, et al. Changes in
medical treatment and surgery rates in inammatory bowel disease: a nationwide cohort study 1979–2011. Gut. 2014;63(10):1607–16. [cited 2017 Aug 14].
21. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre J-P.Impact of the increas-
ing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut. 2005;54(2):237–41. http://www.ncbi.nlm.nih.gov/pubmed/15647188. [cited 2017 Jul 21].
22. Lamb BW, Brown KF, Nagpal K, Vincent C, Green JSA, Sevdalis N.Quality of care man-
agement decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol. 2011;18:2116–25.
23. Limketkai BN, Parian AM, Shah ND, Colombel J-F. Short bowel syndrome and intestinal
failure in Crohn’s disease. Inamm Bowel Dis. 2016;22(5):1209–18. http://www.ncbi.nlm.nih.
gov/pubmed/26818425. [cited 2017 Jun 29].
24. Shah SC, Colombel JF, Sands BE, Narula N.Systematic review with meta-analysis: muco-
sal healing is associated with improved long-term outcomes in Crohn’s disease. Aliment Pharmacol Ther. 2016;43:317–33.
25. de Groof J, Bemelman W, Eshuis E, Gardenbroek T, Bossuyt P, Bosmans J, etal. OP015 Cost-
effectiveness of laparoscopic ileocecal resection versus iniximab treatment of terminal ileitis in Crohn’s disease: the LIR!C TRIAL.J Crohns Colitis. 2017;11(Suppl_1):S9–S10. https://
insights.ovid.com/crohn-colitis/jcac/2017/02/001/op015-cost-effectiveness-laparoscopic-ileo­cecal/15/01337112. [cited 2017 Jul 7].
26. Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated
by strictures: a systematic review. Gut. 2013;62(7):1072–84. https://doi.org/10.1136/
gutjnl-2012-304353. [cited 2017 Jun 30].
27. Burke JP, Mulsow JJ, O’Keane C, Docherty NG, Watson RWG, O’Connell PR.Fibrogenesis
in Crohn’s disease. Am J Gastroenterol. 2007;102(2):439–48. http://www.ncbi.nlm.nih.gov/
pubmed/17156147. [cited 2017 Jul 21].
K. A. T. G. M. Wasmann et al.